Fármacos no combate à tuberculose: passado, presente e futuro

Detalhes bibliográficos
Autor(a) principal: Souza,Marcus Vinícius Nora de
Data de Publicação: 2005
Outros Autores: Vasconcelos,Thatyana Rocha Alves
Tipo de documento: Artigo
Idioma: por
Título da fonte: Química Nova (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422005000400022
Resumo: Approximately every minute, somewhere in the world four people die from tuberculosis (TB), an infection of Mycobacterium tuberculosis with about 3 million deaths per year. In spite of these problems, unfortunaly, it is about 40 years that a novel drug was last introduced on the market. Due to the rapid spread of multi-drug resistant TB strains, resistant against all major anti-tuberculosis drugs, and the recent resurgence of the incidence of tuberculosis in association with the human immunodeficiency virus (HIV) infection and AIDS, we need urgently the development of new drugs to fight tuberculosis. This is covered in the present article.
id SBQ-3_f592bd12a8a85a71cd2891d20a0f3e53
oai_identifier_str oai:scielo:S0100-40422005000400022
network_acronym_str SBQ-3
network_name_str Química Nova (Online)
repository_id_str
spelling Fármacos no combate à tuberculose: passado, presente e futurotuberculosisdrugsantibacterialApproximately every minute, somewhere in the world four people die from tuberculosis (TB), an infection of Mycobacterium tuberculosis with about 3 million deaths per year. In spite of these problems, unfortunaly, it is about 40 years that a novel drug was last introduced on the market. Due to the rapid spread of multi-drug resistant TB strains, resistant against all major anti-tuberculosis drugs, and the recent resurgence of the incidence of tuberculosis in association with the human immunodeficiency virus (HIV) infection and AIDS, we need urgently the development of new drugs to fight tuberculosis. This is covered in the present article.Sociedade Brasileira de Química2005-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422005000400022Química Nova v.28 n.4 2005reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422005000400022info:eu-repo/semantics/openAccessSouza,Marcus Vinícius Nora deVasconcelos,Thatyana Rocha Alvespor2005-08-11T00:00:00Zoai:scielo:S0100-40422005000400022Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2005-08-11T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Fármacos no combate à tuberculose: passado, presente e futuro
title Fármacos no combate à tuberculose: passado, presente e futuro
spellingShingle Fármacos no combate à tuberculose: passado, presente e futuro
Souza,Marcus Vinícius Nora de
tuberculosis
drugs
antibacterial
title_short Fármacos no combate à tuberculose: passado, presente e futuro
title_full Fármacos no combate à tuberculose: passado, presente e futuro
title_fullStr Fármacos no combate à tuberculose: passado, presente e futuro
title_full_unstemmed Fármacos no combate à tuberculose: passado, presente e futuro
title_sort Fármacos no combate à tuberculose: passado, presente e futuro
author Souza,Marcus Vinícius Nora de
author_facet Souza,Marcus Vinícius Nora de
Vasconcelos,Thatyana Rocha Alves
author_role author
author2 Vasconcelos,Thatyana Rocha Alves
author2_role author
dc.contributor.author.fl_str_mv Souza,Marcus Vinícius Nora de
Vasconcelos,Thatyana Rocha Alves
dc.subject.por.fl_str_mv tuberculosis
drugs
antibacterial
topic tuberculosis
drugs
antibacterial
description Approximately every minute, somewhere in the world four people die from tuberculosis (TB), an infection of Mycobacterium tuberculosis with about 3 million deaths per year. In spite of these problems, unfortunaly, it is about 40 years that a novel drug was last introduced on the market. Due to the rapid spread of multi-drug resistant TB strains, resistant against all major anti-tuberculosis drugs, and the recent resurgence of the incidence of tuberculosis in association with the human immunodeficiency virus (HIV) infection and AIDS, we need urgently the development of new drugs to fight tuberculosis. This is covered in the present article.
publishDate 2005
dc.date.none.fl_str_mv 2005-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422005000400022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422005000400022
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 10.1590/S0100-40422005000400022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Química Nova v.28 n.4 2005
reponame:Química Nova (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Química Nova (Online)
collection Química Nova (Online)
repository.name.fl_str_mv Química Nova (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv quimicanova@sbq.org.br
_version_ 1750318104604311552

Registros relacionados